Mercury Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2025 ,inter alia, to consider and approve 1. the Audited Financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mercury Laboratories Ltd has informed BSE that its Board of Directors will meet on Wednesday, May 14, 2025. The main agenda is to consider and approve the audited financial results for the quarter and financial year ended March 31, 2025, along with the draft Directors' Report. The Board will also consider recommending a dividend for FY25 (subject to shareholder approval at the AGM), and approve the appointment of Secretarial, Internal, and Cost Auditors for FY 2025-26. Additionally, the Board will finalise the date, time, and venue of the company's 44th Annual General Meeting. The trading window for insiders has been closed since April 1, 2025 and will reopen 48 hours after the results are declared.
This is a standard advance notice ahead of the full-year results announcement; no financial figures are disclosed yet, so there is no immediate impact on the stock. Investors should watch for the actual results on or after May 14, 2025, along with any dividend declaration.